What does Dr. Anthony Delanote do?

Dr. Anthony Delanote is a general practice in Kortrijk. Private Limited, started on 5 February 2019, 1 establishment.

What is the address of Dr. Anthony Delanote?

The registered office of Dr. Anthony Delanote is located at Tarweveld(Kor) 28 box A, 8500 Kortrijk.

Is Dr. Anthony Delanote still active?

Yes. According to the CBE (18 September 2026) Dr. Anthony Delanote is active, legal situation “Normale toestand”, started on 5 February 2019.

Is Dr. Anthony Delanote registered on Peppol?

Yes, Dr. Anthony Delanote is registered on the Peppol network with ID 0208:0719827496.

What is the enterprise number of Dr. Anthony Delanote?

The enterprise number of Dr. Anthony Delanote is BE0719827496.

When was Dr. Anthony Delanote founded?

Dr. Anthony Delanote was founded on 5 February 2019.

Who are the directors of Dr. Anthony Delanote?

According to the 2025 annual accounts, the directors of Dr. Anthony Delanote are: Anthony Delanote.

Is Dr. Anthony Delanote a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 5 February 2019; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did Dr. Anthony Delanote make in 2025?

Dr. Anthony Delanote posted a profit after taxes of € 118,191 in financial year 2025.

What is the revenue of Dr. Anthony Delanote?

As a small company, Dr. Anthony Delanote is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 176,318.

Dr. Anthony Delanote (Private Limited) - Kortrijk

Dossier Dr. Anthony Delanote, printed on 18 September 2026 from databakkes.be/en/0719827496/dr-anthony-delanote. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

Dr. Anthony Delanote from Kortrijk, company number BE0719827496, closed financial year 2025 with a result of € 118,191 after tax. For that financial year Dr. Anthony Delanote recorded a gross margin of € 176,318 and equity of € 136,791. Compared with financial year 2024, the result moved from € 124,577 to € 118,191. The company is profitable. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on April 14, 2026.

What it is worth Healthy

€ 136,791

▼ 4% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 118,191

▼ 5% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 54,986

▼ 37% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 124,577 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt ≈ 5 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 164,512

€ 32,750 is repaid this year. At this pace the long-term loan is gone in ≈ 5 years.

Owed to suppliers

€ 4,395

▲ € 4,142 vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 2,793

▼ 22% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 125,670 Gross margin 2022: € 125,670 First fiscal year in the series	€ 166,164 Gross margin 2023: € 166,164 ▲ 32% vs 2022 (€ 125,670) Favourable step	€ 177,039 Gross margin 2024: € 177,039 ▲ 7% vs 2023 (€ 166,164) Favourable step	€ 176,318 Gross margin 2025: € 176,318 Unchanged (€ 177,039) Unfavourable step
Profit after taxes	€ 90,617 Profit after taxes 2022: € 90,617 First fiscal year in the series	€ 123,782 Profit after taxes 2023: € 123,782 ▲ 37% vs 2022 (€ 90,617) Favourable step	€ 124,577 Profit after taxes 2024: € 124,577 ▲ 1% vs 2023 (€ 123,782) Favourable step	€ 118,191 Profit after taxes 2025: € 118,191 ▼ 5% vs 2024 (€ 124,577) Unfavourable step	▼ 5%
Equity	€ 20,460 Equity 2022: € 20,460 First fiscal year in the series	€ 18,600 Equity 2023: € 18,600 ▼ 9% vs 2022 (€ 20,460) Unfavourable step	€ 143,177 Equity 2024: € 143,177 ▲ € 124,577 vs 2023 (€ 18,600) Favourable step	€ 136,791 Equity 2025: € 136,791 ▼ 4% vs 2024 (€ 143,177) Unfavourable step	▼ 4%
Total debts	€ 159,744 Total debts 2022: € 159,744 First fiscal year in the series	€ 207,110 Total debts 2023: € 207,110 ▲ 30% vs 2022 (€ 159,744) Unfavourable step	€ 63,722 Total debts 2024: € 63,722 ▼ 69% vs 2023 (€ 207,110) Favourable step	€ 175,149 Total debts 2025: € 175,149 ▲ 175% vs 2024 (€ 63,722) Unfavourable step	▲ 175%
Cash	€ 80,295 Cash 2022: € 80,295 First fiscal year in the series	€ 99,262 Cash 2023: € 99,262 ▲ 24% vs 2022 (€ 80,295) Favourable step	€ 87,185 Cash 2024: € 87,185 ▼ 12% vs 2023 (€ 99,262) Unfavourable step	€ 54,986 Cash 2025: € 54,986 ▼ 37% vs 2024 (€ 87,185) Unfavourable step	▼ 37%
Retained profit	€ 1,860 Retained profit 2022: € 1,860 First fiscal year in the series	€ 0 Retained profit 2023: € 0 ▼ 100% vs 2022 (€ 1,860) Unfavourable step	€ 124,577 Retained profit 2024: € 124,577 Unchanged (€ 0) Favourable step	€ 118,191 Retained profit 2025: € 118,191 ▼ 5% vs 2024 (€ 124,577) Unfavourable step	▼ 5%
Dividend	€ 294,000 Dividend 2022: € 294,000 First fiscal year in the series	€ 125,642 Dividend 2023: € 125,642 ▼ 57% vs 2022 (€ 294,000) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 125,642) Unchanged	€ 124,577 Dividend 2025: € 124,577 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 0 Bank debt 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Bank debt 2024: € 0 Unchanged (€ 0) Unchanged	€ 164,512 Bank debt 2025: € 164,512 Unchanged (€ 0) Unfavourable step
Balance sheet total	€ 180,204 Balance sheet total 2022: € 180,204 First fiscal year in the series	€ 225,710 Balance sheet total 2023: € 225,710 ▲ 25% vs 2022 (€ 180,204) Unchanged	€ 206,899 Balance sheet total 2024: € 206,899 ▼ 8% vs 2023 (€ 225,710) Unchanged	€ 311,940 Balance sheet total 2025: € 311,940 ▲ 51% vs 2024 (€ 206,899) Unchanged	▲ 51%

Key figures of Dr. Anthony Delanote, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Dr. Anthony Delanote?

What happened at Dr. Anthony Delanote in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Apr 14, 2026 New annual accounts for financial year 2025: profit of € 118,191 (▼ 5% vs 2024). Source: NBB ↗
Feb 5, 2019 New establishment in Kortrijk. KBO
Feb 5, 2019 Start of the company according to the CBE. KBO

In short

From € 90,617 profit in 2022 to € 118,191 profit in 2025.

Paid € 155,806 in corporate taxes since 2022.

Best year ever: 2024, with € 124,577 profit.

Paid out € 544,219 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at Dr. Anthony Delanote? We notify you, reason included.

Follow Dr. Anthony Delanote

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Anthony Delanote

Dr. Anthony Delanote

DelDoc

Behind Dr. Anthony Delanote is Anthony Delanote. Anthony Delanote is also behind DelDoc.

See the full network in the app

Directors

According to the 2025 annual accounts

Anthony Delanote

Director

Also active at: DelDoc

Establishments

Establishment units

Physical locations of this company

Registered office

Tarweveld(Kor) 28 box A

8500 Kortrijk

2.285.291.888

Oudenaardsesteenweg(Kor) 14

8500 Kortrijk

Active since 5 February 2019

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

EMILIE OTTÉ ARCHITECTEN

€ 83,815 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0719.827.496

VAT number

BE 0719.827.496

Registered office

Tarweveld(Kor) 28 bus A, 8500 Kortrijk

Names & denominations

Dr. Anthony Delanote

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

5 February 2019

Peppol

Active · Active since 27 Nov 2024

Activities · NACE

Activiteiten van huisartspraktijken

Speur- en ontwikkelingswerk op biotechnologisch gebied

Overige zakelijke dienstverlening, neg

View on CBE Public ↗ Annual accounts (NBB) ↗

Dr. Anthony Delanote

Financials

What happened to Dr. Anthony Delanote?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions